Dr. Sudhir Srivastava is one of the foremost global experts in robotic cardiac surgery. Until date, he has performed the largest number of robotic cardiac procedures in the entire world.
Dr. Srivastava, along with ten additional physicians, founded Alliance Hospital LTD, a center of excellence in the treatment of cardiovascular disease, in Odessa, Texas in July 2003 and served as its chairman for four years. While there, he performed the world’s first single vessel beating heart TECAB in the United States. He also proceeded to perform two world’s first double and triple vessel TECAB on a beating heart and is the only person in the world to have perfomed a quadruple vessel beating heart TECAB while at the University of Chicago.
Dr. Srivastava is an active member of the Society of Thoracic Surgeons, AATS, the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) and is a founder of the Robotic Revascularization Society.
Dr. Srivastava has made it his mission to make available his skill to all those with the desire to learn these minimally invasive techniques. Dr. Srivastava has trained hundreds of teams around the world and is constantly trying to find ways to improve the field of robotic assisted surgery.
Alongside his tireless efforts and determination, Dr. Srivastava continues to push the envelope of surgical science as we know it today
Valluvan Jeevandandam, MD, University of Chicago - Full Bio
Dr. Valluvan Jeevanandam specializes in the surgical management of heart failure, and is an expert in high-risk cardiac surgery. He has performed more than 1,000 heart transplants — including the total artificial heart — and countless cardiac surgery procedures, including transmyocardial laser revascularization, complex valve reconstruction, and minimally invasive coronary artery bypass graft surgery.
Dr. Jeevanandam is a pioneer in the field of mechanical circulatory assist devices. In October 2000, he was the first surgeon in the world to successfully implant the CardioVad, a revolutionary, permanent circulatory assist device that boosts heart function in patients with severe heart failure who are not candidates for transplant.
He continues to be a recognized leader in the field of advanced heart failure and currently serves on the FDA Device Panel. He is a world-renowned surgeon, having started high risk and cardiac assist programs in countries including China, India, the Middle East and South America.
Tim P. Adams, FACHE currently serves as CEO of Tenet’s Texas Region consisting of 22 acute care facilities in Texas with annual net operating revenues in excess of $4 billion. In this role his primary responsibilities included strategic planning, market development, network development, quality improvement, and overall operational and financial performance of the region.
Tim has over 30 years of healthcare experience. Prior to joining Tenet, he served as Division Vice President with Community Health Systems (CHS) and CEO of their hospital in Austin, TX. In his division role he was responsible for the operational and financial performance of CHS’s 18 Texas hospitals with operating net revenues in excess of $1.6 billion.
Tim is board-certified in healthcare management and a Fellow with the American College of Healthcare Executives (FACHE). He received his BA degree from Baylor University and holds a Master’s degree in business administration from the University of Texas in El Paso. Tim serves on THA board of directors as well as several state and national boards.
Vishwa Srivastava, MD, SSI President & COO- Full Bio
Vishwa Srivastava has been involved in the field of robotic assisted surgery since 2008. He completed his premedical courses at Columbia University in New York City and completed his medical degree from Saint James School of Medicine.
In 2009, while working as the Director of Digital Media and Technology at St. Joseph’s Hospital in Atlanta, Vishwa was the first person in the field to develop a high definition teaching website for robotic cardiac surgery. The goal was to assist in cardiothoracic surgeons lessening their respective learning curves through didactic training modules as they transitioned from conventional approaches to minimally invasive robotic approaches.
Soon after, he began his research in the concept of tele-mentoring in surgical procedures. In 2011, while working as the VP of Marketing and Technology at the International Centre for Robotic Surgery in New Delhi, Vishwa led the development of the OMNI 3D Medical Visualization system. The 2013-2014 clinical trials for the OMNI system were conducted at Shanghai Ruijin Hospital, Medanta Hospital in New Delhi, the University of Chicago, Temple University in Philadelphia and Lennox Hill Hospital in New York City.
Vishwa presently serves as the President of OMNI 3D HD and is advancing the existing technological platform for availability in the global surgical endoscopic marketplace.
Mr. Jie Zheng is President of Shulan Health, Vice Director of Zhejiang CNSI Presicion Medical Center, Vice President of Chinese Medical Association International Academy of Digital Medicine. Vice President of Private Hospital Management Branch of Chinese Non-government Medical Institutions Association, Sponser of OMAHA (Open Medical and Healthcare Alliance).
Mr. Maoting Wang was born in Hebei, China, he is a member of the Communist Party of China. He received his bachelor’s degree from Nanjing Southeast University in 1984, and then received MBA from Shanghai Jiaotong University and DBA from Dutch Business School in 2012 and 2015. With the title of Professor Senior Engineer, National Registered Architect and National Registered Consultant Engineer. Currently he is the Chairman of Shanghai NSR Wealth Management Co., Ltd. and Shanghai Lingjun Investment Holding Co., Ltd. And Board of Director of Shanghai Lianchuang Architectural Design Co., Ltd.
‘Mr. Yufeng Jin graduated from Renmin University of China and served as the general manager of Guangsha Wanguo Investment Management Co., Ltd. Managing Director of Hangzhou Wanguo Investment Management Co., Ltd. and the chairman of Hangzhou HEDA Industrial Fund Investment Co., Ltd.
Mr. Li obtained his bachelor degree from Macquarie University in Sydney, he is also an Australian Chartered Accountant with rich experience in accounting and business management. Mr. Li has over 20 years of experience in auditing, investment banking and investment and is managing director of CICC Capital and The Vice Chairman of the Board in Sinopharm-CICC. He previously worked in CICC Investment Banking Division and was the head of Zhejiang business. Mr. Li has rich investment experience in healthcare, TMT, finance, infrastructure, logistics, culture and entertainment industries and was an expert in domestic and overseas IPO, restructuring, refinancing, M&A and bond issuance. During his work in Sinopharm-CICC, Mr. Li has led investments as United Imaging, Fapon Biotech, SSI medical robotics, Landing Medical Science Hightech, Tenry Pharmaceutical, Ribo Life Science, MicuRx Pharmaceuticals, Jilin Tianhe pharmacies M&A, Dingdang Kuaiyao, Cowealth group, Universal Medical Imaging, etc.